Breast cancer affects one in eight women and is the second leading cause of cancer death among women. Led by David H. Gustafson of the University of Wisconsin-Madison, the study set out to examine what type of access to internet resources would be expected to help newly diagnosed breast cancer patients during these stressful months.
To compare the benefits, 257 breast cancer patients were randomly assigned to three groups. The first group, the control group, received standard care and was given their choice of excellent book or audio-tape breast cancer resources. The second group was given a computer and provided with a list of high-quality websites about breast cancer and training on internet use. The third group received access to CHESS, an eHealth system with an integrated set of services related to breast cancer, and training on how to use those specific services.
The patients who received the list of websites did no better than patients in the control group. However, patients in the CHESS group fared better on quality of life, perceived social support, and in dealing with health information and healthcare. CHESS provided added benefits beyond those of simply the internet.
Access to internet services alone provided patients little or no benefit over standard care. On the other hand, access to CHESS helped patients more than standard care and was greatest nine months after they received access to the system, suggesting that CHESS had long term effects on their quality of life.
"Healthcare providers should direct people facing serious illness or injury to a single high-quality website that is comprehensive and regularly updated by objective unbiased experts," the authors conclude. "Patients need to be trained to use the websites they are referred to. The sites need to be more inclusive and contain not only information but support services and tools to help patients think through their situation."
Source: Wiley
Related stories:
Studies spot numerous undiscovered gene alterations in pancreatic and brain cancers
HHMI investigators have detected a multitude of broken, missing, and overactive genes in pancreatic and brain tumors, in the most detailed genetic survey yet of any human tumor. Some of these genetic changes were previously unknown and could provide new leads for improved diagnosis and therapy for these devastating cancers.
Bisphenol A linked to metabolic syndrome in human tissue
New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics—bisphenol A (BPA)—as a risk factor for metabolic syndrome and its consequences.
Potential remedy for the 'mental fog' in cancer patients
Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University (WVU), researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce. The WVU researchers' study has just been published in the September issue of the Springer journal
Metabolic Brain Disease.
Study: New way to spot breast cancer shows promise
(AP) -- A radioactive tracer that "lights up" cancer hiding inside dense breasts showed promise in its first big test against mammograms, revealing more tumors and giving fewer false alarms, doctors reported Wednesday. The experimental method - molecular breast imaging, or MBI - would not replace mammograms for women at average risk of the disease.
World first: Lasers used in keyhole surgery for brain cancer
In a ground-breaking advance, French neurosurgeons on Friday said they had successfully treated brain tumours through ultra-keyhole surgery, using a tiny fibre-optic laser to destroy cancerous cells.
Growth factor predicts poor outcome in breast cancer
The response to insulin-like growth factor 1 (IGF-I) in breast cancer cells predicts an aggressive tumor that is less likely to respond to treatment, said researchers at Baylor College of Medicine in a report that appears in the current issue of the
Journal of Clinical Oncology. The finding gives impetus to the movement to tailor cancer treatments to attributes of the various tumors.
OU researchers developing new tool to detect cancer
Early cancer detection can significantly improve survival rates. Current diagnostic tests often fail to detect cancer in the earliest stages and at the same time expose a patient to the harmful effects of radiation. Led by Dr. Patrick McCann, a small group of internationally known researchers at the University of Oklahoma with expertise in the development of mid-infrared lasers is working to create a sensor to detect biomarker gases exhaled in the breath of a person with cancer.
Low cholesterol associated with cancer in diabetics
Low levels of LDL cholesterol as well as high levels are associated with cancer in patients with type 2 diabetes, found a prospective cohort study published in
CMAJ.